PUBLICATIONS - New from Clinica Reports - Home healthcare Markets (June 2000)
This article was originally published in Clinica
Executive Summary
Home healthcare is a well-established segment of the healthcare delivery system. It originated in the US with the establishment of the first home healthcare agencies in the 1880s and entered a period of rapid expansion in the mid-1960s with the establishment of the US government's Medicare programme to fund care for the elderly. The estimated total spending for home healthcare services in the US in 1999 was $36 billion, which, while a substantial figure, accounts for only about 3-4% of the total expenditure on healthcare in the US.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.